Bexsero: Provides active immunization against invasive meningococcal disease caused by 3 strains of Neisseria meningitidis serogroup B (strains prevalent in the US).
Tremenba: Provides active immunization against invasive meningococcal disease caused by 4 strains of Neisseria meningitidis serogroup B (strains prevalent in the US).
Contraind./Precautions⬆⬇
Contraindicated in:
Severe allergic reaction to a previous dose;
Latex allergy (Bexsero tip caps contain latex).
Use Cautiously in:
Geri: Safe and effective use in patients >65 yr has not been established;
Lactation: Use cautiously if breastfeeding;
OB: Use during pregnancy only if clearly needed;
Pedi: Safe and effective use in children <10 yr not established (>90% risk of fever in infants <12 mo).